Skip to main content

Table 4 Comparison of Length of Stay and Number of Hospitalizations After Conversion to PP1M

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

  Number of hospitalizations Inpatient stays (days)
pre-PP1M 0.67 ± 0.96 52.80 ± 60.54
Post-PP1M 0.22 ± 0.42 16.33 ± 29.48
T 2.56 1.73
P ≤ 0.01 <0.05